GeneGlobe ID: SBM0805533 | Cat. No.: | QuantiNova LNA PCR Assays for Real-Time PCR

MM_CYFIP1_2049636 QuantiNova LNA PCR Assay

Best coverage assay for Cyfip1
Assay targets 6 transcripts
Assay spans exon
Pre-designed assay for dPCR and qPCR.
Assay in Focus Panel

Select a variant to see the price

Product Specification

null
Assay name​
MM_CYFIP1_2049636 QuantiNova LNA PCR Assay
Assay specification​
Best coverage assay for Cyfip1
Assay targets 6 transcripts
Assay spans exon
Pre-designed assay for dPCR and qPCR.
Assay in Focus Panel
Gene symbol​
Cyfip1
Species​
Mus musculus
Main target​
ENSMUST00000173267
Exons numbers​
5-6
Ensembl exons ids​
ENSMUSE00001233531;ENSMUSE00001243359
Amplicon start​
3343
Amplicon length​
103
Assay targets​
Transcript Ensembl Id
Bio Type
Ccds
Ref Seq
Chromosome Location
ENSMUST00000032629
Protein coding
CCDS21315
NM_001164661;NM_011370
Chr.7: 55842071 - 55932602
ENSMUST00000085255
Protein coding
CCDS52262
NM_001164662
Chr.7: 55842206 - 55930498
ENSMUST00000163845
Protein coding
CCDS21315
Chr.7: 55842255 - 55930471
ENSMUST00000173267
Retained intron
Chr.7: 55897074 - 55930498
ENSMUST00000173497
Retained intron
Chr.7: 55842250 - 55925786
ENSMUST00000206862
Protein coding
Chr.7: 55871859 - 55923960
Introducing the MM_CYFIP1_2049636 QuantiNova LNA PCR Assay, a cutting-edge addition to our QuantiNova LNA PCR Assays for Digital PCR lineup, specifically designed for Digital PCR applications. This premium product offers unparalleled performance for researchers working with Mouse models. Leveraging advanced technology, the MM_CYFIP1_2049636 QuantiNova LNA PCR Assay facilitates accurate and reliable results, making it an indispensable tool for your scientific investigations. Whether you're conducting Digital PCR, or any other sophisticated analyses, this product from our QuantiNova LNA PCR Assays for Digital PCR collection ensures optimal efficiency and reproducibility for Mouse studies. Embrace the future of research with MM_CYFIP1_2049636 QuantiNova LNA PCR Assay and elevate your work to new heights.